Fairvalue-Calculator Fairvalue-Calculator
EN DE

PT Citra Tubindo Tbk, (CTBN) Fair Value & Analysis

Energy · ID · Market cap 5.1T IDR

Price5,525 IDR
Fair Value6,821 IDR
Upside+23.5%
Quality95/100
Evidence: High Range 5,026 IDR – 8,616 IDR

Analysis

PT Citra Tubindo Tbk, (CTBN) currently trades at 5,525 IDR, while our model-based Fair Value estimate is 6,821 IDR — implying the stock looks roughly 23.5% undervalued today. We read business quality at 95/100 (high quality), in the Energy sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

PT Citra Tubindo Tbk, together with its subsidiaries, provides pipes and accessories, and related services to the oil and gas industries in Indonesia. The company operates through Pipe Processing; Transportation Services and Others, and Technical Support segments. The company offers finishing and threading of pipes; and heat treatment process for seamless pipes, as well as manufactures accessories. It also provides technical support services related to intellectual property. In addition, the company offers port, transportation, and stevedoring services. It exports its products. PT Citra Tubindo Tbk was incorporated in 1983 and is headquartered in Batam, Indonesia.

Open the full interactive analysis →

Similar stocks

SLB N.V (SLBN) -45% Baker Hughes Company (BKR) -53% Halliburton Company (HAL) -55% Tenaris S.A (T1SS34) -34% TechnipFMC plc (FTI) -57% Yantai Jereh Oilfield Services Group (002353) -63%

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.